Macrogenics INC (MGNX) SEC Filings — 2024
23 SEC filings for Macrogenics INC (MGNX) in 2024.
Filings
- MacroGenics Appoints New Director — 8-K · Nov 21, 2024
- Macrogenics INC SC 13G Filing — SC 13G · Nov 20, 2024
- Macrogenics INC SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Macrogenics INC SC 13G/A Filing — SC 13G/A · Nov 8, 2024
- MacroGenics Q3 Revenue Surges to $36.6M — 10-Q · Nov 5, 2024
- MacroGenics Announces CMO Departure and Appointment — 8-K · Oct 30, 2024
- Macrogenics INC SC 13G/A Filing — SC 13G/A · Oct 22, 2024
- MacroGenics Terminates Henlius Biotech Deal — 8-K · Sep 16, 2024
- MacroGenics Q2 Revenue Declines to $35.7M — 10-Q · Aug 6, 2024
- MacroGenics Appoints New Chief Medical Officer — 8-K · Jul 30, 2024
- Macrogenics INC SC 13G Filing — SC 13G · Jun 4, 2024
- MacroGenics Files 8-K on Shareholder Vote Matters — 8-K · May 23, 2024
- Macrogenics INC SC 13G Filing — SC 13G · May 21, 2024
- Macrogenics Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- MacroGenics Announces Annual Meeting of Stockholders on May 21, 2024 — DEF 14A · Apr 8, 2024
- MacroGenics Files 8-K Report — 8-K · Apr 3, 2024
- Macrogenics Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 7, 2024
- Macrogenics INC SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Macrogenics INC SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Macrogenics INC SC 13G Filing — SC 13G · Feb 14, 2024
- Macrogenics INC SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Macrogenics INC SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- BlackRock Amends MACROGENICS Stake, Maintains Passive Position — SC 13G/A · Jan 24, 2024